Brain Tumor Biomarker Holds Steady at Recurrence, Reshaping Chemo Rechallenge Decisions
A large paired-cohort study finds MGMT promoter methylation remains quantitatively stable in 84 percent of recurrent gliomas, with apparent status ...
A large paired-cohort study finds MGMT promoter methylation remains quantitatively stable in 84 percent of recurrent gliomas, with apparent status ...
A German study of 121 patients finds that amino acid tracer uptake on preoperative FET PET is independently associated with ...
A retrospective study of 154 glioblastoma patients found that 5-ALA and sodium fluorescein produced nearly identical resection volumes, yet 5-ALA ...
A Johns Hopkins study of 69 patients maps intradural spinal metastasis as a late stage of cancer spread, showing median ...
A qualitative study of clinicians, exercise specialists, and administrators involved in a neuro-oncology exercise program finds that electronic referral pathways ...
A Toronto study reports that salvage conventionally fractionated Gamma Knife radiotherapy achieved durable tumor control with few severe side effects ...
Researchers have validated a blood-based panel of ten circulating microRNAs that can differentially diagnose glioblastoma, astrocytoma, oligodendroglioma, meningioma, and brain ...
Researchers in Beijing have built patient-derived organoids from adult ependymoma tumors with high efficiency, showing that the cultures preserve key ...
A single-center study of 14 adults found proton radiotherapy delivered durable tumor control, 100 percent five-year survival, and predominantly mild ...
A new single-center study shows that adult-onset intracranial germ cell tumors are an underrecognized cause of sellar and suprasellar lesions ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine